Similar articles

• Modelling SARS-CoV-2 CNS infection.

  Weber C. Weber C. Nat Cell Biol. 2021 Sep;23(9):927. doi: 10.1038/s41556-021-00756-0. Nat Cell Biol. 2021. PMID: 34497372 No abstract available.
• Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.

  Stefano GB, Büttiker P, Weissenberger S, Martin A, Ptacek R, Kream RM. Stefano GB, et al. Med Sci Monit. 2021 May 10;27:e933015. doi: 10.12659/MSM.933015. Med Sci Monit. 2021. PMID: 34016942 Free PMC article.
• After the WHO report: what's next in the search for COVID's origins.

  Mallapaty S. Mallapaty S. Nature. 2021 Apr;592(7854):337-338. doi: 10.1038/d41586-021-00877-4. Nature. 2021. PMID: 33790440 No abstract available.
• SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.

  Trevisan M, Riccetti S, Sinigaglia A, Barzon L. Trevisan M, et al. Int J Mol Sci. 2021 Feb 26;22(5):2356. doi: 10.3390/ijms22052356. Int J Mol Sci. 2021. PMID: 33652988 Free PMC article. Review.
• Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19.

  Samet JM. Samet JM. Nicotine Tob Res. 2020 Dec 15;22(12 Suppl 2):S93-S95. doi: 10.1093/ntr/ntaa187. Nicotine Tob Res. 2020. PMID: 33320258 Free PMC article. Review.